An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.
Active Trade on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where groups with numerous of participants share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Experts Voice Worries
However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.
Several professionals said the popularity for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.
Platform Reaction and Material Removal
Based on TikTok, the platform has taken down problematic material and prohibited related keywords and query recommendations. The company said it was committed to keeping the service safe and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Research also discovered communities with up to 9,000 members selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of users, populated with images of slimming results, glowing testimonials and detailed guides for preparing or administering at home.
Within minutes of joining one community, a vendor posted contact information, where the majority of transactions take place. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, medical conditions or previous experience.
Product Details and Costs
Inside these communities, posts show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram stated it actively monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her team has already seen patients injured by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Producer Position
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose users to potentially significant health risks”.
